Certified by Founder Lodge
Novalis Biotech
Belgium - Ghent, Flemish Region
INVESTOR
1 Disclosed Funding Rounds $1,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Novalis Biotech is an early stage venture capital fund in life sciences, focusing on enabling technologies in healthcare, such as digital health, diagnostics, genomics and bio-informatics.
| Company | Date | Round | Raised |
|---|---|---|---|
Alithea Genomics |
May, 24 ,2022 | Seed | $1,000,000 |
Alithea Genomics
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Allos | $5,000,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)